Replies to post #607910 on NorthWest Biotherapeutics Inc (NWBO)

[iclight]

The FDA doesn’t care about DCvax and the company won’t even submit an application for approval so it’s a moot point.

SOC has patients living that long and they didn’t cherry pick the top 20% of best prognosis patients like the DCVax glorified placebo trial.

[HyGro]

Dubious clinical trial data is the likely reason. Here's a list of 7 publications responding to NWBO's JAMA Oncology publication: https://pubmed.ncbi.nlm.nih.gov/?term=DCVax-L+2023